脑膜瘤中H3K27me3缺失的预后价值:多中心研究
该多中心研究对181例脑膜瘤行H3K27me3免疫组化染色,在151例染色清晰者中21例(13.9%)呈肿瘤细胞完全缺失而内皮细胞保留。H3K27me3缺失提示更差结局,尤其在WHO 2级肿瘤中复发时间更短;但多变量Cox回归校正WHO分级、切除程度、性别、年龄及肿瘤复发状态后,H3K27me3缺失并非无复发生存期的独立相关因素。
要点
- H3K27me3缺失见于部分WHO 2级及可能的WHO 1级脑膜瘤,复发风险增加。
- WHO 3级患者中H3K27me3保留与缺失的无复发生存期无差异。
- 三档评分系统未增加H3K27me3缺失的预后价值。
核心结论
- H3K27me3缺失可识别一部分WHO 2级及可能WHO 1级脑膜瘤中复发风险增加者。
- 校正WHO分级、切除程度、性别、年龄及肿瘤复发状态后,H3K27me3缺失并非RFS的独立相关因素。
研究设计与样本
- 多中心研究,对181例脑膜瘤的全切片行H3K27me3免疫组化染色,其中151例染色清晰者纳入分析。
- 采用二分类(缺失与保留)及三档评分系统分析染色结果,并用Kaplan-Meier生存估计分析分组与结局的关联。
主要发现
- 151例中21例(13.9%)肿瘤细胞H3K27me3染色完全缺失而内皮细胞染色保留。
- H3K27me3缺失提示更差结局,本队列中复发时间更短,尤其在WHO 2级肿瘤中更明显。
- WHO 3级患者中H3K27me3保留与缺失的无复发生存期无差异。
- 三档评分系统未对该缺失的预后价值提供更多信息。
局限性
- 需对更大队列样本开展汇总分析,并统一临床定义与染色模式的报告标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a critical need for objective and reliable biomarkers of outcome in meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a prognostically unfavorable alteration in meningiomas. We sought to independently evaluate the reproducibility and prognostic value of H3K27me3 loss by immunohistochemistry (IHC) in a multicenter study. METHODS: IHC staining for H3K27me3 and analyses of whole slides from 181 meningiomas across three centers was performed. Staining was analyzed by dichotomization into loss and retained immunoreactivity, and using a 3-tiered scoring system in 151 cases with clear staining. Associations of grouping with outcome were performed using Kaplan-Meier survival estimates. RESULTS: A total of 21 of 151 tumors (13.9%) demonstrated complete loss of H3K27me3 staining in tumor with retained endothelial staining. Overall, loss of H3K27me3 portended a worse outcome with shorter times to recurrence in our cohort, particularly for WHO grade 2 tumors which were enriched in our study. There were no differences in recurrence-free survival (RFS) for WHO grade 3 patients with retained vs loss of H3K27me3. Scoring by a 3-tiered system did not add further insights into the prognostic value of this H3K27me3 loss. Overall, loss of H3K27me3 was not independently associated with RFS after controlling for WHO grade, extent of resection, sex, age, and recurrence status of tumor on multivariable Cox regression analysis. CONCLUSIONS: Loss of H3K27me3 identifies a subset of WHO grade 2 and possibly WHO grade 1 meningiomas with increased recurrence risk. Pooled analyses of a larger cohort of samples with standardized reporting of clinical definitions and staining patterns are warranted.
引用
- Nassiri F, Wang JZ, Singh O, et al. Loss of H3K27me3 in meningiomas. Neuro Oncol. 2021. PMID: 33970242. doi:10.1093/neuonc/noab036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。